biosimilar medicinal products working party
- Definition
- The BMWP provides recommendations to the CHMP on clinical or non-clinical matters relating directly or indirectly to biosimilar medicinal products, and on the conduct of tests on biosimilar medicinal products. These tests are needed to ensure the comparability of the old and new versions of biological medicinal products,when manufacturers make changes to such products during their lifecycle, or choose to develop new products which are biologically similar that could effect their quality, safety of efficacy.
- Abbreviation for
- BMWP
- Broader Term
- working party
- Related Term
- biosimilar medicinal product
Send comments to info@qdossier.com Please read disclaimer before using Qsauri.